Explore our materials

Filters

Results (14767)

Viral Hepatitis and Liver Disease

Puerto Rico Meeting on Hepatitis & HIV 2019

A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically suppressed HIV-1 infected adult subjects harboring the NRTI resistance mutation M184V and/or M184I (GS-US

Viral Hepatitis and Liver Disease

Puerto Rico Meeting on Hepatitis & HIV 2019

Acceptability and concerns over the use of PrEP in Puerto Rico

INTEREST 2019

PopART in Zambia and South Africa: What Have We Learned? - Albertus Schaap, MSc

INTEREST 2019

Symp3_introduction

INTEREST 2019

97_JLIintro

INTEREST 2019

Characterizing the HIV Epidemic among 15-24 Year Olds in Urban Ethiopia, 2017-18 - Aderonke Ajiboye

INTEREST 2019

Economic Burden of Accessing Treatment on People Living with HIV; Outcomes of a Cross-Sectional Survey in Lagos State, Nigeria - Adewale Ogunnaike

INTEREST 2019

Application of Machine Learning Models in Prediction of PrEP Retention among High-risk Persons in Uganda - Agnes Kiragga

INTEREST 2019

Prevalence of Cervical HPV Infection among Women Living with HIV in Harare, Zimbabwe - Ardele Maureen Mandiriri

INTEREST 2019

Factors Associated with Liver Injury among HIV Infected Children and Adolescents Attending a National Referral Pediatric HIV Clinic in Uganda - Bonny Mulindwa

INTEREST 2019

Three Billboards on West African Adolescent HIV Prevention Studies: Rights, Complexities and Possible Solutions - Ann Strode, BA, LLB, LLM, PhD

INTEREST 2019

The Importance of Science and Innovation for the Global Fund - Christoph Benn